Valeriandoid B is primarily studied for its potential neuroprotective and anxiolytic properties. It interacts with GABAergic pathways in the central nervous system, suggesting utility in managing anxiety and sleep disorders. Research indicates it may enhance GABA receptor activity, which can promote calming effects without significant sedation. This makes it a candidate for development in natural therapeutics for mild to moderate anxiety. It is also being explored for its anti-inflammatory effects in neurological tissues, potentially offering benefits in neurodegenerative conditions. Due to its natural origin and structural profile, it serves as a lead compound in designing novel central nervous system modulators.